InvestSMART

Beamtree Holdings Limited (ASX: BMT) - Share Price

- Current share price for BMT : $0.091

Beamtree Holdings Limited (BMT) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It a provider of AI based decision support and data insights solutions and other software services to the healthcare industry. It helps solve healthcare problems around the world by turning data into insights, action and automation. It is a provider of technology software and services in Australia and is expanding its reach globally with its products used by over 300 end customers in 25 countries.

BMT General Information +

ASX Code BMT
Website http://beamtree.com.au
Industry/Sector Health Care Technology
Market Cap ($M) 26
BMT Share Price $0.091
Day High $0.091
Day Low $0.091
Last Close $0.091
BMT Share Price Movement - ( No change )
Prices as at 10:31, 14 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Beamtree Holdings Limited (BMT) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Beamtree Holdings Limited (BMT) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Beamtree Holdings Limited (BMT) price-sensitive announcements

BMT - Beamtree appoints Gareth Pye as Chief Executive Officer
Beamtree Holdings Limited announced the appointment of Gareth Pye as the new Chief Executi
Beamtree Holdings Limited (BMT)
15 Jun 2026 | 9:51 AM
BMT - $2m Saudi contract win & Strategic Review Interim Update
Beamtree Holdings Limited announced a significant contract win worth $2 million with Fakee
Beamtree Holdings Limited (BMT)
5 May 2026 | 9:33 AM
BMT - 1H FY26 Results - Investor Presentation
Beamtree Holdings Limited presented its 1H FY26 results, showcasing a strategic focus on r
Beamtree Holdings Limited (BMT)
19 Feb 2026 | 8:34 AM
BMT - BMT FY26 Half-Year Investor Update
Beamtree Holdings Limited reported a strategic focus on advancing its AI-based healthcare
Beamtree Holdings Limited (BMT)
19 Feb 2026 | 8:31 AM

Beamtree Holdings Limited (BMT) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Beamtree Holdings Limited (BMT)
ORDINARY FULLY PAID
Health Care $27 Notification of cessation of securities - BMT 6 Oct 2026 7:04PM $0.090 $0.091 risen by 1.11%
Beamtree Holdings Limited (BMT)
ORDINARY FULLY PAID
Health Care $27 Change of Director's Interest Notice - M Hill 3 Sep 2026 5:07PM $0.110 $0.091 fallen by 17.27%
Beamtree Holdings Limited (BMT)
ORDINARY FULLY PAID
Health Care $27 Change of Director's Interest Notice - M Bowles 31 Aug 2026 4:27PM $0.110 $0.091 fallen by 17.27%
Beamtree Holdings Limited (BMT)
ORDINARY FULLY PAID
Health Care $27 Cleansing Notice 28 Aug 2026 11:39AM $0.130 $0.091 fallen by 30%
Beamtree Holdings Limited (BMT)
ORDINARY FULLY PAID
Health Care $27 Application for quotation of securities - BMT 28 Aug 2026 11:37AM $0.130 $0.091 fallen by 30%
Beamtree Holdings Limited (BMT)
ORDINARY FULLY PAID
Health Care $27 Appendix 4G and Corporate Governance Statement 28 Aug 2026 9:08AM $0.130 $0.091 fallen by 30%

BMT Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$4.59 -$1.60 -20.20% 0.00 0.00 0.00% 0.0%
2025A -$5.75 -$2.00 1.00% 0.00 0.00 0.00% 0.0%
2024A -$5.50 -$2.00 -35.30% 0.00 0.00 0.00% 0.0%

BMT Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
4DMedical Limited (4DX) $2,541M 1.7823 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Artrya Limited (AYA) $499M -0.0450 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Beamtree Holdings Limited (BMT) $27M -0.2020 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $17,590M 1.3034 -0.2811 0.2395 66.3920 92.3537 74.5066 0.41% 0.55% 0.68%

BMT Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.13 0.00
Market 0.31 13.80 1.06 0.72
Sector 0.73 21.20 1.95 2.47

BMT Directors

Name Position Start Date
Ms Emma Gray Executive Chairman, Executive Director 24 Nov 2022
Mr Michael (Mike) Hastings Hill Non-Executive Director 26 Jun 2018
Professor Andrew(Andy) Ian Hardy Non-Executive Director 31 Mar 2025
Mr Stuart MacDonald Non-Executive Director 15 Oct 2025
Mr Martin Bowles Non-Executive Director 2 Mar 2026

Beamtree Holdings Limited (BMT) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
3 Sep 2026 HILL, Michael (Mike) Buy Indirect Shares 86,000 $0.115 $9,890.000
31 Aug 2026 BOWLES, Martin Buy Indirect Shares 80,000 $0.120 $9,600.000
23 Jun 2026 HILL, Michael (Mike) Buy Indirect Shares 68,970 $0.145 $10,000.650

See all changes in directors' interest & trades for Beamtree Holdings Limited (BMT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

BMT Management

Name Position
Gareth Pye Chief Executive Officer
Maria Clemente Company Secretary

BMT Calendar of Events

Date Event
27 August 2027 Report (Annual)
27 August 2027 Report (Prelim)
18 February 2027 Report (Interim)
26 November 2026 AGM

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.